Article Details
Retrieved on: 2022-08-30 10:11:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
MA owned approximately 0.08% of Vir Biotechnology as of its most recent filing with the SEC. Several other large investors have also modified their ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here